Sarcosine: Clinical Trials

7 trials of Sarcosine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 withdrawn. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Completed 6, Withdrawn 1

Follow Sarcosine: new trials by email Literature Review of Sarcosine trials Research Report on Sarcosine

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Sarcosine - Schizophrenia
Phase 2CompletedMedical University of Lodz702012-01-012016-09-16
N-methylglycine (Sarcosine) Treatment for Depression
citalopram, sarcosine - Major Depressive Disorder, Depression
Phase 2CompletedChina Medical University Hospital402009-04-012011-07-12
Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia
sarcosine, sarcosine+ BE, placebo - Schizophrenia
Phase 2CompletedChang-Hua Hospital632009-03-012014-07-08
N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
N-methyl glycine - Obsessive Compulsive Disorder
Phase 2CompletedChina Medical University Hospital302007-06-012009-12-29
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
Sarcosine (N-methylglycine) - Schizophrenias, Psychoses
Phase 2WithdrawnHerzog Hospital2006-08-012014-06-04
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Sarcosine and D-serine - Schizophrenias, Psychoses
Phase 2CompletedChina Medical University Hospital602005-01-012007-06-26
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
Sarcosine - Schizophrenias, Psychoses
Phase 2CompletedChina Medical University Hospital202004-12-012006-05-19

Conditions studied

Schizophrenia (5)  ·  Psychotic Disorders (3)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Obsessive-Compulsive Disorder (1)

Sponsors

China Medical University Hospital (4)  ·  Chang-Hua Hospital (1)  ·  Herzog Hospital (1)  ·  Medical University of Lodz (1)

Countries

Taiwan (5)  ·  Israel (1)  ·  Poland (1)

Top investigators

Bernard Lerer, M.D. (1)  ·  Chieh-Liang Huang, MD (1)  ·  Chun-yuan Lin, MD (1)  ·  Dominik Strzelecki, MD, PhD (1)  ·  Guochuan E Tsai, MD, PhD (1)  ·  Guochuan E. Tsai, MD,PhD (1)  ·  Hsien-Yuan Lane, M.D., Ph.D (1)  ·  Hsien-Yuan Lane, MD,PhD (1)  ·  Hsien-yuan Lane, MD,PHD (1)  ·  Hsien-yuan Lane, MD,PhD (1)  ·  Uriel Heresco-Levy, M.D. (1)

Results publications

PMID 17659263, PMID 19887019, PMID 23562005, PMID 26306650, PMID 26501260, PMID 34510411, PMID 41929255